The DOI matches its OpenAlex record; 49 of the 49 references it cites were found in a registry or an index.
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
Open accessAbstract
The induction of potent CD8+ T cell responses by vaccines to fight microbes or tumors remains a major challenge, as many candidates for human vaccines have proved to be poorly immunogenic. Deoxycytidyl-deoxyguanosin oligodeoxynucleotides (CpG ODNs) trigger Toll-like receptor 9, resulting in dendritic cell maturation that can enhance immunogenicity of peptide-based vaccines in mice. We tested whether a synthetic ODN, CpG 7909, could improve human tumor antigen-specific CD8+ T cell responses. Eight HLA-A2+ melanoma patients received 4 monthly vaccinations of low-dose CpG 7909 mixed with melanoma antigen A (Melan-A; identical to MART-1) analog peptide and incomplete Freund's adjuvant. All patients exhibited rapid and strong antigen-specific T cell responses: the frequency of Melan-A-specific T cells reached over 3% of circulating CD8+ T cells. This was one order of magnitude higher than the frequency seen in 8 control patients treated similarly but without CpG and 1-3 orders of magnitude higher than that seen in previous studies with synthetic vaccines. The enhanced T cell populations consisted primarily of effector memory cells, which in part secreted IFN- and expressed granzyme B and perforin ex vivo. In vitro, T cell clones recognized and killed melanoma cells in an antigen-specific manner. Thus, CpG 7909 is an efficient vaccine adjuvant that promotes strong antigen-specific CD8+ T cell responses in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“stimulate DC activation through TLR9 triggering (8, 9), leading to enhanced T cell responses specific for coadministered antigens in”
BackgroundTwo subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“called tetramers) were prepared as described previously (42, 51) with Melan-A analog peptide26–35 ELAGIGILTV.”
MethodApproaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Self-citationKadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Innate immunity: impact on the adaptive immune response
Medzhitov, R., & Janeway, C. A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80152-5 · Cited by 1,558
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
Kawabe, Y., & Ochi, A. (1991) · Nature · doi:10.1038/349245a0 · Cited by 662
Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324032 · Cited by 595
Self-citationHartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldschmidt, M., Sajuthi, D., Purcell, R. H., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1617 · Cited by 585
Self-citationPhenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96.
Altman, J. D., Moss, P. A. H., Goulder, P., Barouch, D. H., McHeyzer‐Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (2011) · PubMed · Cited by 572
Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells
Takeshita, F., Leifer, C. A., Gursel, I., Ishii, K. J., Takeshita, S., Gursel, M., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3555 · Cited by 570
Sprent, J., & Surh, C. D. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100101.151926 · Cited by 534
Human Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs
Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2372 · Cited by 529
Weiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 519
Self-citationPittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Liénard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.-C., & Romero, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.705 · Cited by 508
Self-citationHeikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., Zinkernagel, R., & Aguzzi, A. (2004) · Nature Medicine · doi:10.1038/nm987 · Cited by 449
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., & Ahmed, R. (2003) · Nature Medicine · doi:10.1038/nm866 · Cited by 396
Lipford, G. B., Bauer, M., Blank, C., Reiter, R., Wagner, H., & Heeg, K. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270931 · Cited by 383
Priming of naive T cells inside tumors leads to eradication of established tumors
Yu, P., Lee, Y., Liu, W., Chin, R. K., Wang, J., Wang, Y., Schietinger, A., Philip, M., Schreiber, H., & Fu, Y.-X. (2004) · Nature Immunology · doi:10.1038/ni1029 · Cited by 356
Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S., & Endres, S. (2003) · European Journal of Immunology · doi:10.1002/eji.200323813 · Cited by 296
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.
Cormier, J. N., Salgaller, M. L., Prevette, T., Barracchini, K. C., Rivoltini, L., Restifo, N. P., Rosenberg, S. A., & Marincola, F. M. (1997) · PubMed · Cited by 277
Halperin, S. A., Van Nest, G., Smith, B., Abtahi, S., Whiley, H., & Eiden, J. J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00045-8 · Cited by 259
Marshall, J. D., Fearon, K., Abbate, C., Subramanian, S., Yee, P., Gregorio, J., Coffman, R. L., & Van Nest, G. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202630 · Cited by 259
Salio, M., Palmowski, M. J., Atzberger, A., Hermans, I. F., & Cerundolo, V. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031059 · Cited by 201
Subversion of the immune system by pathogens
Marrack, P., & Kappler, J. (1994) · Cell · doi:10.1016/0092-8674(94)90339-5 · Cited by 199
Rufer, N., Zippelius, A., Batard, P., Pittet, M. J., Kurth, I., Corthesy, P., Cerottini, J.-C., Leyvraz, S., Roosnek, E., Nabholz, M., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0420 · Cited by 182 · cited 3×
“cDNA preparation, cDNA amplification, and PCR were done using primers for CD3, granzyme B, perforin, IFN-γ, TNF-γ, and CD94 as described (33).”
MethodInfluentialSelf-citationRomero, P., Valmori, D., Pittet, M. J., Zippelius, A., Rimoldi, D., Lévy, F., Dutoit, V., Ayyoub, M., Rubio‐Godoy, V., Michielin, O., et al. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18808.x · Cited by 164
Self-citationImmunostimulatory CpG-Oligodeoxynucleotides Cause Extramedullary Murine Hemopoiesis
Sparwasser, T. D., Hültner, L., Koch, E. S., Luz, A., Lipford, G. B., & Wagner, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2368 · Cited by 147
CpG Are Efficient Adjuvants for Specific CTL Induction Against Tumor Antigen-Derived Peptide
Miconnet, I., Koenig, S., Speiser, D. E., Krieg, A. Μ., Guillaume, P., Cerottini, J., & Romero, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1212 · Cited by 147
Self-citationIFN-α and IFN-β: a link between immune memory and chronic inflammation
Akbar, A. N., Lord, J. M., & Salmon, M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01652-2 · Cited by 145
Dávila, E., & Celis, E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.539 · Cited by 141
Vabulas, R. M., Pircher, H., Lipford, G. B., Häcker, H., & Wagner, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2372 · Cited by 140
Oxenius, A., Martinic, M. M. A., Hengartner, H., & Klenerman, P. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4120-4126.1999 · Cited by 129
Schaed, S. G., Klimek, V. M., Panageas, K. S., Musselli, C., Butterworth, L., Hwu, W., Livingston, P. O., Williams, L. J., Lewis, J. J., Houghton, A. N., et al. (2002) · PubMed · Cited by 107
Líénard, D., Rimoldi, D., Marchand, M., Dietrich, P., van Baren, N., Geldhof, C., Batard, P., Guillaume, P., Ayyoub, M., Pittet, M. J., et al. (2004) · PubMed · Cited by 72
Self-citationPowell, D. J., & Rosenberg, S. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200401000-00004 · Cited by 71
Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization
Monsurrò, V., Nielsen, M.-B., Pérez‐Díez, A., Dudley, M. E., Wang, E., Rosenberg, S. A., & Marincola, F. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5817 · Cited by 56
Speiser, D. E., Pittet, M. J., Rimoldi, D., Guillaume, P., Luescher, I. F., Líénard, D., Lejeune, F. J., Cerottini, J., & Romero, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.010 · Cited by 55
Self-citationPullarkat, V. A., Lee, P. P., Scotland, R., Rubio, V., Groshen, S. G., Gee, C., Lau, R., Snively, J., Sian, S., Woulfe, S. L., et al. (2003) · PubMed · Cited by 41
Speiser, D. E., Pittet, M. J., Guillaume, P., Lübenow, N., Hoffman, E. W., Cerottini, J., & Romero, P. J. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200407000-00006 · Cited by 39
Self-citationBoon, T., & den Eynde, B. V. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00010-4 · Cited by 36
Disease-driven T cell activation predicts immune responses to vaccination against melanoma.
Speiser, D. E., Rimoldi, D., Batard, P., Líénard, D., Lejeune, F. J., Cerottini, J., & Romero, P. J. (2003) · PubMed · Cited by 22
Self-citation
Cited by
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Self-citationMelief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Designer vaccine nanodiscs for personalized cancer immunotherapy
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017) · Nature Materials · doi:10.1038/nmat4822 · Cited by 1,056
Metadata
- Authors
- Speiser, D. E., Líénard, D., Rufer, N., Rubio‐Godoy, V., Rimoldi, D., Lejeune, F. J., Krieg, A. Μ., Cerottini, J., & Romero, P. J.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2005-02-04
- Volume
- 115
- Issue
- 3
- Pages
- 739-746
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2095224835
- Cited by
- 640
- References
- 49
- FWCI
- 22.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.